TOP 5 MOST VIEWED ARTICLES
RECENT COMMENTS
-
Henry R Shibata: A thoughtful and timely article. Agree with the sentiments expressed and only wish that [...] »Read more
-
David Ryner (don't play with numbers): I agree with Duncan and thank you Kathy. I number myself amongst many who suffer from a cr [...] »Read more
-
Duncan Jefferson (don't play with numbers): A very common sense article and one that should be taken on board by all in the Health "In [...] »Read more
-
Ken Campbell (recording consultations): I am clinical information offider for a UK cancer charity. I often recommend to patients t [...] »Read more
-
Frank (recording consultations): Yes I had a pt request a consultation with me - I am concerned about the medicolegal aspec [...] »Read more
-
Nicola Nicolai, Lara Bellardita, Massimo Maffezzini, Tiziana Magnani, Riccardo Valdagni and the Prostate Cancer Program Multidisciplinary Team at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan: The topic is of great interest, with good points in favour as well as against the referral [...] »Read more
-
Marian marie: It was next to impossible to manage my Thyroid Cancer after I had a Thyroidectomy in 1976. [...] »Read more
-
Paul CORNES (centralising cancer services): Thank you both - I enjoyed reading this. The best systematic review on the topic comes [...] »Read more
-
Steven Vermeulen: I was diagnose with adenocarcinoma with unknown primary in Oct. 2009. I was 54 years old, [...] »Read more
-
Wolfgang Grisold (cancer treatment: agesim): Thank you for raising this interesting issue. Personally , I have the impression that at l [...] »Read more
Drug Watch
Issue 32
Gotta get that rhythm: circadian timing systems and cancer
Issue 31
Beyond trench warfare: American and European researchers in search of a winning strategy
Issue 30
Health rationing in Europe: can cancer get a fair hearing?
Issue 28
Oncology’s successes must not fail the heart
Issue 27
When is it OK to randomise cancer patients to placebo?
Issue 26
Stopping trials prematurely: sorting the right decisions from the wrong
Issue 25
Personalised medicine: the dream and the reality
Issue 24
How Europe is taking on the big biobank challenge
Issue 21
Dying for a lack of compassion?
Issue 20
Healthcare rationing: the moral dilemma
Issue 19
HPV vaccine promises much but screening remains vital
Issue 18
Bringing personalised cancer treatments to the people
Issue 17
No-name heroes can save Europe billions
Issue 16
Fast and effective?
Issue 13
RNA-bound: the future of antisense drugs
Issue 12
PHARE: shining a light for academic reasearch in
Issue 5
Brainwaves in drug delivery
Issue 4
Let’s talk Chinese milk vetch
Issue 3
Europe set to act over paediatric drugs
Issue 1
Cancer vaccines – hope or hype
CancerWorld invites you to visit:
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.

